triumeq filmtabletten
viiv healthcare gmbh - dolutegravirum, abacavirum, lamivudinum - filmtabletten - dolutegravirum 50 mg zu dolutegravirum natricum, abacavirum 600 mg bis abacaviri sulfas, lamivudinum 300 mg, mannitolum, cellulosum microcristallinum, povidonum k 29-32, carboxymethylamylum natricum, magnesium stearas, Überzug: talkum, macrogolum, poly(alkohol vinylicus), e 171, e 172, für compresso haze endwerte. natrium 6.5 - 8.93 mg. - hiv-infektion - synthetika
triumeq
viiv healthcare b.v. - dolutegravir sodium, lamivudine, abacavir (as sulfate) - hiv-infektionen - antivirale mittel zur systemischen anwendung - triumeq is indicated for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children weighing at least 25 kg who are antiretroviral treatment-naïve or are infected with hiv without documented or clinically suspected resistance to any of the three antiretroviral agents in triumeq.
triumeq tabletten zur herstellung einer suspension zum einnehmen
viiv healthcare gmbh - dolutegravirum, abacavirum, lamivudinum - tabletten zur herstellung einer suspension zum einnehmen - dolutegravirum 5 mg ut dolutegravirum natricum, abacavirum 60 mg ut abacaviri sulfas, lamivudinum 30 mg, mannitolum, cellulosum microcristallinum, povidonum k 29-32, carboxymethylamylum natricum a, cellulosum microcristallinum silicificatum, crospovidonum, acesulfamum kalicum, sucralosum, natrii stearylis fumaras, aromatica erdbeercrèmearoma, Überzug: talcum, macrogolum 4000, poly(alcohol vinylicus), e 171, e 172 (flavum), pro compresso obducto corresp. natrium 0.9 mg. - hiv-infektion - synthetika